Pakistan heart drugs: Lahore death toll reaches 100

Pakistani heart patients return faulty medicine at the Punjab Institute of Cardiology Patients who still had supplies of the faulty medicine have been returning them.

Related Stories

More than 100 people have now died in Lahore after taking contaminated heart medicine, Pakistan officials have said.

The deaths, which span a three-week period, are linked to a batch of faulty drugs given to up to 40,000 cardiac patients at a government-run hospital.

Another 250 people remain in hospital while an investigation into the situation gets under way.

The owners of three local drugs companies alleged to have supplied the contaminated drugs have been arrested.

Government official Shahbaz Sharif said the victims tended to be poor people who had received the drugs free, the news agency AFP reported. He said action would be taken against anyone found guilty.

Samples of the drugs had been sent to laboratories in Pakistan, London and Paris for testing.

The deaths caused panic in the city less than three months after a dengue fever epidemic.

Officials have warned that the batch of contaminated drugs might have been distributed to nearly 40,000 people since 15 December. They say that patients affected by the substandard drugs suffer a rapid depletion of white cells and blood platelets.

Suffering families

The symptoms - first noticed in late December - created an impression that patients were suffering a form of dengue fever, a mosquito-borne disease common in Pakistan during the monsoon season, officials say.

Start Quote

All patients are suffering from bleeding from the mouth and urinary tracts”

End Quote Asim Saeed

But patient data soon revealed that all of those affected were heart patients who had been using free cardiovascular drugs from the government-run Punjab Institute of Cardiology.

On Wednesday relatives of the dead and sick told the BBC how their families had suffered.

Parveen Bib showed the BBC her father's death certificate and said: "My father died on 23 December after taking the contaminated medicine. There was bleeding from his mouth and also bleeding from his urinary tract."

Cardiac patients seek treatment at the Punjab Institute of Cardiology Many of those affected are poor patients

Asim Saeed said: "All patients are suffering from bleeding from the mouth and urinary tracts. We have been in the hospital for seven days but no-one came to check on us. They would sneak in quietly - doctors would check patients and go away."

Officials said one or more of at least six drugs - all manufactured by little-known local firms and purchased by the Institute of Cardiology for heart patients - may be responsible.

Officials of the Federal Investigation Agency (FIA) told a court in Lahore on Wednesday that the drugs did not carry dates of manufacture and expiry.

The court has remanded in custody three people who own pharmaceutical firms which supplied the drugs to the Institute of Cardiology. The owners of two other companies are being sought..

None of the firms has commented on the allegations.

The medicines have been removed from hospitals and stores

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Asia stories


Features & Analysis

  • Martin Gardner as a young manThink hard

    Was this man the world's greatest puzzle master?

  • Carved pumpkinTrick or treat

    What did a riot at a pumpkin festival show about race in US?

  • A woman puts on a surgical mask during hospital Ebola training in Alabama.'Dark continent'

    Is prejudice fuelling Ebola outbreak hysteria in the US?

  • Oscar de la Renta and Oprah WinfreyIn pictures

    The life and work of Oscar de la Renta

Elsewhere on the BBC

  • FutureThe future is now

    Get the latest updates and biggest ideas from BBC Future’s World-Changing Ideas Summit


  • Smart glassesClick Watch

    Smart spectacles go into battle – the prototypes looking to take on Google Glass

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.